Pathophysiology and Terminology: Distinguishing Septicaemia from Sepsis

In clinical practice, the terms “septicaemia” and “sepsis” are often used interchangeably by patients, but they represent distinct pathophysiological states.

• Septicaemia: Refers specifically to the presence of pathogens (bacteria, fungi, or viruses) in the bloodstream. While it indicates a systemic infection, it does not necessarily imply organ dysfunction.
• Sepsis: Defined by the Sepsis-3 consensus, sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. The pathophysiology involves an overwhelming systemic inflammatory response (cytokine storm) that leads to microvascular coagulation, endothelial damage, and subsequent tissue hypoxia.
• Septic Shock: A subset of sepsis characterized by profound circulatory, cellular, and metabolic abnormalities. It is clinically identified by the requirement of vasopressors to maintain a mean arterial pressure (MAP) $\ge$≥ 65 mmHg and a serum lactate level $>2$>2 mmol/L despite adequate fluid resuscitation.

Risk Stratification and Predisposing Factors

While any infection can trigger sepsis, clinicians should maintain a high index of suspicion in patients with compromised host defenses:

• Immunocompromised States: HIV/AIDS (low CD4 counts), hematologic malignancies, and solid organ transplant recipients on immunosuppressants (e.g., mycophenolate, corticosteroids).
• Metabolic Dysregulation: Diabetes mellitus (increased susceptibility to UTI and skin infections) and chronic kidney disease (CKD).
• Chronic Physiological Stress: Advanced age, malnutrition (protein-energy wasting), liver cirrhosis (leading to impaired immune function), and chronic smoking.
• Iatrogenic Factors: Recent chemotherapy, long-term steroid use, or indwelling medical devices (central lines, urinary catheters).

Clinical Presentation and Early Recognition Tools

Sepsis is a medical emergency where “time is tissue.” Rapid recognition via validated scoring systems is critical.

1. Clinical Manifestations

• Early Signs: Fever or hypothermia, tachycardia, tachypnea, and altered mental status (confusion/agitation).
• Signs of Hypoperfusion: Delayed capillary refill time, mottled skin, cold extremities, and oliguria.
• Septic Shock Progression: Hypotension (systolic BP <90 mmHg or drop from baseline), profound lethargy, and multi-organ dysfunction syndrome (MODS).

2. Screening Tools

• qSOFA (quick Sequential Organ Failure Assessment): While controversial in its use for general screening due to sensitivity issues, it remains a useful bedside tool for identifying patients at high risk of mortality. Criteria include:
  1. Altered mental status (GCS <15).
  2. Systolic BP $\le$≤ 100 mmHg.
  3. Respiratory rate $\ge$≥ 22 breaths/min.
• SOFA Score: The gold standard for diagnosing sepsis in clinical settings, assessing dysfunction in the respiratory, coagulation, hepatic, renal, central nervous, and hematologic systems.

Diagnostic Workup

Diagnosis must be rapid; do not delay treatment for definitive imaging if the patient is unstable.

1. Microbiology (The “Gold Standard”):
   • Blood Cultures: Obtain at least two sets (aerobic and anaerobic) from different sites prior to antibiotic administration, but do not delay antibiotics if cultures are difficult to obtain.
   • Source Cultures: Sputum, urine, wound swabs, or CSF depending on the suspected focus.
2. Laboratory Markers:
   • Lactate: A critical marker of tissue hypoxia and anaerobic metabolism. Serial lactate monitoring is essential for assessing resuscitation adequacy.
   • Complete Blood Count (CBC): Look for leukocytosis, leukopenia, or a “left shift” (increased immature band neutrophils). Thrombocytopenia is a strong predictor of poor prognosis.
   • Inflammatory Markers: CRP and Procalcitonin (Procalcitonin can assist in differentiating bacterial from non-bacterial etiology, though it should not be used in isolation).
   • Organ Function Panels: Creatinine/BUN (renal), AST/ALT/Bilirubin (hepatic), Coagulation profile (PT/INR/D-dimer for DIC monitoring), and Arterial Blood Gas (ABG) for acid-base status.
3. Imaging: Chest X-ray (pneumonia), CT abdomen (abscess/perforation), Echocardiogram (endocarditis/cardiac dysfunction).

Evidence-Based Management Strategies

Management should follow the “Surviving Sepsis Campaign” bundles.

The Hour-1 Bundle:

1. Measure lactate level: Re-measure if initial lactate is $>2$>2 mmol/L.
2. Obtain blood cultures before administering antibiotics.
3. Administer broad-spectrum antibiotics: Empiric therapy should cover likely pathogens based on the suspected source and local antibiograms.
4. Fluid Resuscitation: For patients with hypotension or lactate $\ge 4$≥4 mmol/L, administer at least 30 mL/kg of intravenous crystalloid.
5. Vasopressors: If the patient remains hypotensive during or after fluid resuscitation to maintain MAP $\ge$≥ 65 mmHg. Norepinephrine is the first-line agent.

Advanced Management:

• Source Control: Prompt surgical or radiological intervention (e.g., abscess drainage, debridement of necrotic tissue) is mandatory to remove the nidus of infection.
• Glycemic Control: Maintain blood glucose in a target range (typically 140–180 mg/dL) to prevent complications from hyperglycemia.
• Steroid Therapy: Low-dose intravenous corticosteroids (e. dose Hydrocortisone) are indicated for patients with septic shock who require escalating doses of vasopressors.

Complications and Prognosis

Sepsis is a systemic catastrophe that can lead to:

• MODS/Multi-Organ Failure: Acute Kidney Injury (AKI), Acute Respiratory Distress Syndrome (ARDS), and hepatic failure.
• Coagulopathy: Disseminated Intravascular Coagulation (DIC) leading to both microvascular thrombosis and hemorrhage.
• Mortality: Mortality rates remain high, particularly in septic shock. Abdominal sepsis carries a significantly higher mortality rate (often exceeding 70% in critical care settings). Survivors often face Post-Sepsis Syndrome (PSS), involving long-term cognitive impairment, muscle weakness, and psychological morbidity.

Disclaimer: This summary is intended for medical professionals and serves as an educational overview. Clinical decisions should be based on individual patient presentation and institutional protocols.